HopeStage
Back to all studies
CompletedNCT04052568

Psilocybin for Long-Term Anorexia: An Early Study

About this titleRead the official source — NCT04052568
Medication studyAges 18–65United StatesEating disorders
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
BaltimoreSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: August 26, 2019
Recruitment status
Completed
Enrollment listed in the registry
22
Sponsor
Johns Hopkins University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT04052568
Official title
Show the full official title

Effects of Psilocybin in Anorexia Nervosa

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Baltimore

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Johns Hopkins University, a university.

Did this study involve medication?

Yes. The study involved medication, including Psilocybin.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies